Skip to main content
Top
Published in:

Open Access 15-06-2024 | Circulatory Disease | Review

Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review

Authors: Arif Albulushi, Aisha Al Balushi, Muhhamed Shahzad, Ismail Al Bulushi, Hatim Al Lawati

Published in: Cardio-Oncology | Issue 1/2024

Login to get access

Abstract

The landscape of cancer survivorship is increasingly populated by individuals facing a spectrum of cardiometabolic risks, attributed to both their oncological history and treatment regimens. This manuscript synthesizes findings from various studies, highlighting the prevalence of traditional risk factors—hypertension, dyslipidemia, diabetes—as well as emergent concerns like obesity and metabolic syndrome among survivors. The impact of demographic variables, specific cancer types, and treatment modalities on cardiometabolic health is explored. Through a lens of multidisciplinary management and future research directives, we advocate for an integrative approach to cardiometabolic health in cancer survivors, aiming to ensure their victory over cancer extends into long-term well-being.

Graphical Abstract

Literature
1.
go back to reference Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36.CrossRefPubMed Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36.CrossRefPubMed
2.
go back to reference Zullig LL, Sung AD, Khouri MG, et al. Cardiometabolic comorbidities in Cancer survivors: JACC: CardioOncology State-of-the-art review. JACC CardioOncol. 2022;4(2):149–65.CrossRefPubMedPubMedCentral Zullig LL, Sung AD, Khouri MG, et al. Cardiometabolic comorbidities in Cancer survivors: JACC: CardioOncology State-of-the-art review. JACC CardioOncol. 2022;4(2):149–65.CrossRefPubMedPubMedCentral
3.
4.
go back to reference Denlinger CS, Carlson RW, Are M, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):34–45.CrossRefPubMedPubMedCentral Denlinger CS, Carlson RW, Are M, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):34–45.CrossRefPubMedPubMedCentral
8.
go back to reference Howden EJ, La Gerche A, Arthur JF, et al. Standing up to the cardiometabolic consequences of hematological cancers. Blood Rev. 2018;32(5):349–60.CrossRefPubMed Howden EJ, La Gerche A, Arthur JF, et al. Standing up to the cardiometabolic consequences of hematological cancers. Blood Rev. 2018;32(5):349–60.CrossRefPubMed
9.
go back to reference Simon MS, Hastert TA, Barac A, et al. Cardiometabolic risk factors and survival after cancer in the women’s Health Initiative. Cancer. 2021;127(4):598–608.CrossRefPubMed Simon MS, Hastert TA, Barac A, et al. Cardiometabolic risk factors and survival after cancer in the women’s Health Initiative. Cancer. 2021;127(4):598–608.CrossRefPubMed
10.
go back to reference Felicetti F, Fortunati N, Brignardello E. Cancer survivors: an expanding population with an increased cardiometabolic risk. Diabetes Res Clin Pract. 2018;143:432–42.CrossRefPubMed Felicetti F, Fortunati N, Brignardello E. Cancer survivors: an expanding population with an increased cardiometabolic risk. Diabetes Res Clin Pract. 2018;143:432–42.CrossRefPubMed
11.
go back to reference Florido R, Daya NR, Ndumele CE, et al. Cardiovascular Disease Risk among Cancer survivors: the Atherosclerosis Risk in communities (ARIC) Study. J Am Coll Cardiol. 2022;80(1):22–32.CrossRefPubMedPubMedCentral Florido R, Daya NR, Ndumele CE, et al. Cardiovascular Disease Risk among Cancer survivors: the Atherosclerosis Risk in communities (ARIC) Study. J Am Coll Cardiol. 2022;80(1):22–32.CrossRefPubMedPubMedCentral
12.
go back to reference Belzile-Dugas E, Eisenberg MJ. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology [published correction appears in J Am Heart Assoc. 2023;12(10):e027687]. J Am Heart Assoc. 2021;10(18):e021686. Belzile-Dugas E, Eisenberg MJ. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology [published correction appears in J Am Heart Assoc. 2023;12(10):e027687]. J Am Heart Assoc. 2021;10(18):e021686.
14.
go back to reference Chow EJ, Chen Y, Armstrong GT, et al. Underdiagnosis and Undertreatment of Modifiable Cardiovascular risk factors among survivors of Childhood Cancer. J Am Heart Assoc. 2022;11(12):e024735.CrossRefPubMedPubMedCentral Chow EJ, Chen Y, Armstrong GT, et al. Underdiagnosis and Undertreatment of Modifiable Cardiovascular risk factors among survivors of Childhood Cancer. J Am Heart Assoc. 2022;11(12):e024735.CrossRefPubMedPubMedCentral
15.
go back to reference Cohen JB, Geara AS, Hogan JJ, Townsend RR. Hypertension in Cancer patients and survivors: Epidemiology, diagnosis, and management. JACC CardioOncol. 2019;1(2):238–51.CrossRefPubMedPubMedCentral Cohen JB, Geara AS, Hogan JJ, Townsend RR. Hypertension in Cancer patients and survivors: Epidemiology, diagnosis, and management. JACC CardioOncol. 2019;1(2):238–51.CrossRefPubMedPubMedCentral
18.
go back to reference Bhatnagar R, Dixit NM, Yang EH, Sallam T. Cancer therapy’s impact on lipid metabolism: mechanisms and future avenues. Front Cardiovasc Med. 2022;9:925816.CrossRefPubMedPubMedCentral Bhatnagar R, Dixit NM, Yang EH, Sallam T. Cancer therapy’s impact on lipid metabolism: mechanisms and future avenues. Front Cardiovasc Med. 2022;9:925816.CrossRefPubMedPubMedCentral
19.
go back to reference Custódio ID, Marinho Eda C, Gontijo CA, Pereira TS, Paiva CE, Maia YC. Impact of Chemotherapy on Diet and Nutritional Status of women with breast Cancer: a prospective study. PLoS ONE. 2016;11(6):e0157113.CrossRefPubMedPubMedCentral Custódio ID, Marinho Eda C, Gontijo CA, Pereira TS, Paiva CE, Maia YC. Impact of Chemotherapy on Diet and Nutritional Status of women with breast Cancer: a prospective study. PLoS ONE. 2016;11(6):e0157113.CrossRefPubMedPubMedCentral
20.
go back to reference Romero SAD, Jones L, Bauml JM, Li QS, Cohen RB, Mao JJ. The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer. 2018;26(10):3423–30.CrossRefPubMedPubMedCentral Romero SAD, Jones L, Bauml JM, Li QS, Cohen RB, Mao JJ. The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer. 2018;26(10):3423–30.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: a current overview of Epidemiology, Pathogenesis, outcomes, and management. Cancers (Basel). 2023;15(2):485.CrossRefPubMed Pati S, Irfan W, Jameel A, Ahmed S, Shahid RK. Obesity and Cancer: a current overview of Epidemiology, Pathogenesis, outcomes, and management. Cancers (Basel). 2023;15(2):485.CrossRefPubMed
25.
go back to reference De Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11(2):193–203.CrossRefPubMed De Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol. 2010;11(2):193–203.CrossRefPubMed
26.
go back to reference Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy Diet for Cardiovascular Disease Prevention: where are we now? Vasc Health Risk Manag. 2023;19:237–53.CrossRefPubMedPubMedCentral Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy Diet for Cardiovascular Disease Prevention: where are we now? Vasc Health Risk Manag. 2023;19:237–53.CrossRefPubMedPubMedCentral
27.
go back to reference Keaver L, O’Callaghan N, Douglas P. Nutrition support and intervention preferences of cancer survivors. J Hum Nutr Diet. 2023;36(2):526–39.CrossRefPubMed Keaver L, O’Callaghan N, Douglas P. Nutrition support and intervention preferences of cancer survivors. J Hum Nutr Diet. 2023;36(2):526–39.CrossRefPubMed
28.
go back to reference Misiąg W, Piszczyk A, Szymańska-Chabowska A, Chabowski M. Physical activity and Cancer Care-A Review. Cancers (Basel). 2022;14(17):4154.CrossRefPubMed Misiąg W, Piszczyk A, Szymańska-Chabowska A, Chabowski M. Physical activity and Cancer Care-A Review. Cancers (Basel). 2022;14(17):4154.CrossRefPubMed
29.
go back to reference Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for Cancer survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.CrossRefPubMedPubMedCentral Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for Cancer survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.CrossRefPubMedPubMedCentral
30.
go back to reference Barre PV, Padmaja G, Rana S, Tiamongla. Stress and quality of life in Cancer patients: medical and psychological intervention. Indian J Psychol Med. 2018;40(3):232–8.CrossRefPubMedPubMedCentral Barre PV, Padmaja G, Rana S, Tiamongla. Stress and quality of life in Cancer patients: medical and psychological intervention. Indian J Psychol Med. 2018;40(3):232–8.CrossRefPubMedPubMedCentral
31.
go back to reference Patel SR, Suero-Abreu GA, Ai A, Ramachandran MK, Meza K, Florez N. Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations. Front Oncol. 2023;13:1124447.CrossRefPubMedPubMedCentral Patel SR, Suero-Abreu GA, Ai A, Ramachandran MK, Meza K, Florez N. Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations. Front Oncol. 2023;13:1124447.CrossRefPubMedPubMedCentral
32.
33.
go back to reference Shelburne N, Adhikari B, Brell J, et al. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014;106(9):dju232.CrossRefPubMedPubMedCentral Shelburne N, Adhikari B, Brell J, et al. Cancer treatment-related cardiotoxicity: current state of knowledge and future research priorities. J Natl Cancer Inst. 2014;106(9):dju232.CrossRefPubMedPubMedCentral
34.
go back to reference Ferdinand KC, Senatore FF, Clayton-Jeter H et al. Improving Medication Adherence in Cardiometabolic Disease: practical and Regulatory implications. J Am Coll Cardiol. Ferdinand KC, Senatore FF, Clayton-Jeter H et al. Improving Medication Adherence in Cardiometabolic Disease: practical and Regulatory implications. J Am Coll Cardiol.
35.
go back to reference Bisceglia I, Canale ML, Silvestris N, et al. Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals. Front Cardiovasc Med. 2023;10:1223660.CrossRefPubMedPubMedCentral Bisceglia I, Canale ML, Silvestris N, et al. Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals. Front Cardiovasc Med. 2023;10:1223660.CrossRefPubMedPubMedCentral
Metadata
Title
Navigating the crossroads: cardiometabolic risks in cancer survivorship – a comprehensive review
Authors
Arif Albulushi
Aisha Al Balushi
Muhhamed Shahzad
Ismail Al Bulushi
Hatim Al Lawati
Publication date
15-06-2024
Publisher
BioMed Central
Published in
Cardio-Oncology / Issue 1/2024
Electronic ISSN: 2057-3804
DOI
https://doi.org/10.1186/s40959-024-00240-2

Other articles of this Issue 1/2024

Cardio-Oncology 1/2024 Go to the issue
Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine